Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Ocular Therapeut
(NQ:
OCUL
)
6.290
+0.120 (+1.94%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocular Therapeut
< Previous
1
2
3
4
5
6
7
Next >
AffaMed Therapeutics, licensee of DEXTENZA® in Certain Asian Markets, Doses Their First Patient in Clinical Trial Evaluating the Safety and Efficacy of DEXTENZA® in China in Cataract Surgery Patients
January 18, 2022
From
Ocular Therapeutix, Inc.
Via
Business Wire
Ocular Therapeutix™ to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
January 04, 2022
From
Ocular Therapeutix, Inc.
Via
Business Wire
Ocular Therapeutix's Dexamethasone Ophthalmic Insert Meets Primary Goal In Dry Eye Disease Trial
December 06, 2021
Ocular Therapeutix Inc (NASDAQ: OCUL) announced topline results from its Phase 2 trial of OTX-DED (dexamethasone intracanalicular ophthalmic insert) for the short-...
Via
Benzinga
Expert Ratings For Ocular Therapeutix
November 09, 2021
Ocular Therapeutix (NASDAQ:OCUL) has observed the following analyst rating...
Via
Benzinga
Ocular Therapeutix™ Announces Topline Results for Phase 2 Clinical Trial of OTX-DED for the Short-Term Treatment of Dry Eye Disease
December 06, 2021
From
Ocular Therapeutix, Inc.
Via
Business Wire
Ocular Therapeutix™ to Participate at Two Upcoming Investor Conferences
November 15, 2021
From
Ocular Therapeutix, Inc.
Via
Business Wire
Ocular Therapeutix Stock Gains As Court Invalidates Drug Delivery Patent From Mati
November 09, 2021
Ocular Therapeutix Inc (NASDAQ:OCUL) announce...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 09, 2021
Gainers Frequency Therapeutics (NASDAQ:FREQ) stock rose 10.94% to $7.51 during Tuesday's regular session. The current volume of 277.7K shares is 160.43% of Frequency...
Via
Benzinga
Ocular Therapeutix™ Announces Success in Patent Appeal Brought by Mati Therapeutics, Inc.
November 09, 2021
From
Ocular Therapeutix, Inc.
Via
Business Wire
Ocular Therapeutix: Q3 Earnings Insights
November 08, 2021
Ocular Therapeutix (NASDAQ:OCUL) reported its Q3 earnings results on Monday, November 8, 2021 at 04:01 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Ocular Therapeutix™ Reports Third Quarter 2021 Financial Results and Business Update
November 08, 2021
From
Ocular Therapeutix, Inc.
Via
Business Wire
Ocular Therapeutix™ Announces Update from the Centers for Medicare and Medicaid Services (CMS) for the Reimbursement of DEXTENZA®
November 05, 2021
From
Ocular Therapeutix, Inc.
Via
Business Wire
Earnings Scheduled For November 8, 2021
November 08, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •...
Via
Benzinga
Ocular Therapeutix™ to Present Data at the American Academy of Optometry Annual Meeting 2021
November 01, 2021
From
Ocular Therapeutix, Inc.
Via
Business Wire
Ocular Therapeutix™ To Report Third Quarter 2021 Financial Results
October 29, 2021
From
Ocular Therapeutix, Inc.
Via
Business Wire
Ocular Therapeutix™ to Present Data at the American Academy of Ophthalmology (AAO) 2021 Virtual Annual Meeting
October 28, 2021
From
Ocular Therapeutix
Via
Business Wire
What 5 Analyst Ratings Have To Say About Ocular Therapeutix
October 25, 2021
Ocular Therapeutix (NASDAQ:OCUL) has observed the following analyst ratings...
Via
Benzinga
How The Future Looks For Last Week's Biggest Losers: Vinco Ventures, Atea Pharmaceuticals And More
October 25, 2021
Last week, the five biggest stock market losers declined between about 75% and 37%. Below is a look at each stock and what they may have in the cards going forward. Galera...
Via
Benzinga
10 Biggest Price Target Changes For Monday
October 25, 2021
Wells Fargo boosted Bank of America Corporation (NYSE:B...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 22, 2021
Gainers Progenity (NASDAQ:PROG) stock increased by 18.48% to $2.96 during Friday's regular session. Progenity's stock is trading at a volume of 116.0 million...
Via
Benzinga
Mid-Day Market Update: Snap Drops After Q3 Results; Creatd Shares Jump
October 22, 2021
Midway through trading Friday, the Dow traded up 0.25% to 35,690.68 while the NASDAQ fell 0.46% to 15,145.78. The S&P also rose, gaining 0.02% to 4,550.53. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
55 Biggest Movers From Friday
October 25, 2021
Gainers Phunware, Inc. (NASDAQ: PHUN) shares jumped 471.2% to close at $8.74 on Friday. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World...
Via
Benzinga
35 Stocks Moving In Friday's Mid-Day Session
October 22, 2021
Gainers Phunware, Inc. (NASDAQ: PHUN) rose 1099% to $18.35. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World Acquisition as traders circulated...
Via
Benzinga
Here's Why Ocular Therapeutix Stock Is Sinking Today
October 22, 2021
The company's experimental dry-eye treatment produced some disappointing clinical trial results.
Via
The Motley Fool
Ocular Therapeutix™ Announces Topline Results for Phase 2 Clinical Trial of OTX-CSI for the Treatment of Dry Eye Disease Did Not Meet Primary Endpoint
October 22, 2021
From
Ocular Therapeutix, Inc.
Via
Business Wire
10 Biggest Price Target Changes For Monday
October 18, 2021
Barclays reduced the price target for The Walt Disney Company (NYSE:
Via
Benzinga
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
October 18, 2021
Biotech stocks rebounded in the week ended Oct. 15, bouncing from third straight weekly losses. The strength came amid a broader market rally and some sector-specific news....
Via
Benzinga
Exposures
Product Safety
46 Biggest Movers From Yesterday
October 12, 2021
Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares jumped 93.9% to close at $35.36 on Monday. The FDA removed the full clinical hold on Protagonist Therapeutics’...
Via
Benzinga
Exposures
Product Safety
Why Are Ocular Therapeutix Shares Trading Higher Today?
October 11, 2021
The FDA has approved Ocular Therapeutix Inc's (NASDAQ: OCUL) supplemental application to broaden the Dextenza label. The approval now adds an indication for...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Monday's Intraday Session
October 11, 2021
Gainers Protagonist Therapeutics (NASDAQ:PTGX) shares increased by 92.43% to $35.1 during Monday's regular session. Trading volume for this security as of 12:30 EST is...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.